Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients

Journal of Neuro-Oncology

Volumn 124, Issue 2, 2015, Pages 317-323

  Zairi, Fahed ^a   Le Rhun, Emilie ^a,b   Bertrand, Nicolas ^b   Boulanger, Thomas ^b   Taillibert, Sophie ^c   Aboukais, Rabih ^a   Assaker, Richard ^a   Chamberlain, Marc C ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE OSCAR LAMBRET   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Complications; Infection intraventricular intra CSF treatment; Leptomeningeal meningitis; Ventricular access device

Indexed keywords

CYTARABINE; METHOTREXATE; THIOTEPA; ANTINEOPLASTIC ANTIMETABOLITE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BREAST CANCER; CATHETER DISLOCATION; CONTROLLED STUDY; DEVICE INFECTION; FATALITY; FEMALE; FOLLOW UP; HUMAN; INTRAVENTRICULAR ACCESS DEVICE; LEUKOENCEPHALOPATHY; LOCAL ANESTHESIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MENINGEAL METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; PATIENT COMPLIANCE; PATIENT SAFETY; PEROPERATIVE COMPLICATION; PERSONAL EXPERIENCE; PRIMARY TUMOR; PROSPECTIVE STUDY; SEX DIFFERENCE; SOLID TUMOR; VASCULAR EQUIPMENT; ADVERSE EFFECTS; BRAIN; BREAST TUMOR; DEVICES; INDWELLING CATHETER; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LUNG TUMOR; MENINGEAL NEOPLASMS; MIDDLE AGED; PATHOLOGY; SECONDARY; SPINAL CORD;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN; BREAST NEOPLASMS; CATHETERS, INDWELLING; CYTARABINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENTRICULAR; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MENINGEAL NEOPLASMS; MIDDLE AGED; PROSPECTIVE STUDIES; SPINAL CORD;

EID: 84942500269     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1842-x     Document Type: Article

References (36)

1. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR (1978) Meningeal carcinomatosis in breast cancer. Cancer 42:283–286
2. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK (1978) Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 42:660–668
3. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103–119
4. Le Rhun E, Taillibert S, Chamberlain MC (2013) Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int 4:S265–S288
5. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23:3605–3613
6. DeAngelis LM (1998) Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 38:245–252
7. Blaney SM, Poplack DG (2000) Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol 17:151–162
8. Pace P, Fabi A (2006) Chemotherapy in neoplastic meningitis. Crit Rev Oncol Hematol 60:528–534
9. Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Chamberlain MC et al (2008) Central nervous system cancers: clinical practice guidelines in oncology. J Natl Compr Cancer Netw 6:456–504
10. Bokstein F, Lossos A, Siegal T (1998) Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82:1756–1763
11. Chamberlain MC (2009) Leptomeningeal metastasis. Curr Opin Neurol 22:665–674
12. Glantz MJ, Van Horn A, Fisher R, Chamberlain MC (2010) Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Cancer 116:1947–1952
13. Shapiro WR, Young DF, Mehta BM (1975) Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293:161–166
14. Ratcheson RA, Ommaya AK (1968) Experience with the subcutaneous cerebrospinal-fluid reservoir. Preliminary report of 60 cases. N Engl J Med 279:1025–1031
15. Obbens EA, Leavens ME, Bed JW, Lee YY (1985) Ommaya reservoirs in 387 cancer patients. A 15-year experience. Neurology 35:1274
16. Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH (2000) Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 47:49–55
17. Ommaya AK (1963) Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 282:983–984
18. Lishner M, Perrin RG, Feld R, Messner HA, Tuffnell PG, Elhakim T, Matlow A, Curtis JE (1990) Complications associated with Ommaya reservoirs in patients with cancer: the Princess Margaret Hospital experience and review of the literature. Arch Intern Med 150:173
19. Bleyer WA, Pizzo PA, Spence AM, Platt WD, Benjamin DR, Kolins CJ, Poplack DG (1978) The Ommaya reservoir. Newly recognized complications and recommendations for insertion and use. Cancer 41:2431–2437
20. Zairi F, Le Rhun E, Tetard MC, Kotecki N, Assaker R (2011) Complications related to the placement of an intraventricular chemotherapy device. J Neurooncol 104:247–252
21. Balm M, Hammack J (1996) Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol 53:626–632
22. Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters BC, Recht LD (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82:733–739
23. Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA et al (2011) National comprehensive cancer network, central nervous system. J Natl Compr Canc Netw 9:352–400
24. Jaeckle KA (2006) Neoplastic meningitis from systemic malignancies: diagnosis, prognosis, and treatment. Semin Oncol 33:312–323
25. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74:1449–1454
26. Chamberlain MC, Kormanik PA, Barba D (1997) Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87:694–699
27. Pirotte BJ, Lubansu A, Bruneau M, Loqa C, Van Cutsem N, Brotchi J (2007) Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 23:1251–1261
28. Mead PA, Safdieh JE, Nizza P, Tuma S, Sepkowitz KA (2014) Ommaya reservoir infections: a 16-year retrospective analysis. J Infect 68:225–230
29. Szvalb AD, Raad II, Weinberg JS, Suki D, Mayer R, Viola GM (2014) Ommaya reservoir-related infections: clinical manifestations and treatment outcomes. J Infect 68:216–224
30. Kosier MB, Minkler P (1999) Nursing management of patients with an implanted Ommaya reservoir. Clin J Oncol Nurs 3:63–67
31. Lishner M, Scheinbaum R, Messner HA (1991) Intrathecal vancomycin in the treatment of Ommaya reservoir infection by Staphylococcus epidermidis. Scand J Infect Dis 23:101–104
32. Siegal T, Pfeffer MR, Steiner I (1988) Antibiotic therapy for infected Ommaya reservoir systems. Neurosurgery 22:97–100
33. Bleyer WA, Pizzo PA, Spence AM, Platt WD, Benjamin DR, Kolins CJ, Poplack DG (1978) The Ommaya reservoir. newly recognized complications and recommendations for insertion and use. Cancer 41:2431–2437
34. Stone JA, Castillo M, Mukherji SK (1999) Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy. Neuroradiology 41:134–136
35. Chowdhary SA, Chamberlain MC (2006) An unusual complication of Ommaya reservoirs and intraventricular chemotherapy. Neurology 67(2):319–320
36. Chamberlain MC (2012) Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. J Neurooncol 109:143–148